Li L, Li W (June 2015). „Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation“. Pharmacology & Therapeutics. 150: 33–46. doi:10.1016/j.pharmthera.2015.01.004. PMID25595324.
Peinado H, Olmeda D, Cano A (2007). „Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?“. Nature Reviews Cancer. 7 (6): 415–428. doi:10.1038/nrc2131. hdl:10261/81769. PMID17508028. S2CID25162191.
De Craene B, Berx G (2013). „Regulatory networks defining EMT during cancer initiation and progression“. Nature Reviews Cancer. 13 (2): 97–110. doi:10.1038/nrc3447. PMID23344542. S2CID13619676.
Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (April 2008). „The role of ATF-2 in oncogenesis“. BioEssays. 30 (4): 314–27. doi:10.1002/bies.20734. PMID18348191. S2CID678541.
Li JJ, Huang YQ, Basch R, Karpatkin S (February 2001). „Thrombin induces the release of angiopoietin-1 from platelets“. Thrombosis and Haemostasis. 85 (2): 204–6. doi:10.1055/s-0037-1615677. PMID11246533. S2CID33522255.
Gowda C, Sachdev M, Muthusami S, Kapadia M, Petrovic-Dovat L, Hartman M, et al. (2017). „Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies“. Current Pharmaceutical Design. 23 (1): 95–107. doi:10.2174/1381612822666161006154311. PMID27719640.
Zhang J, Tian XJ, Zhang H, Teng Y, Li R, Bai F, et al. (September 2014). „TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops“. Science Signaling. 7 (345): ra91. doi:10.1126/scisignal.2005304. PMID25270257. S2CID19143040.
Li L, Li W (June 2015). „Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation“. Pharmacology & Therapeutics. 150: 33–46. doi:10.1016/j.pharmthera.2015.01.004. PMID25595324.
Peinado H, Olmeda D, Cano A (2007). „Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?“. Nature Reviews Cancer. 7 (6): 415–428. doi:10.1038/nrc2131. hdl:10261/81769. PMID17508028. S2CID25162191.
De Craene B, Berx G (2013). „Regulatory networks defining EMT during cancer initiation and progression“. Nature Reviews Cancer. 13 (2): 97–110. doi:10.1038/nrc3447. PMID23344542. S2CID13619676.
Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (April 2008). „The role of ATF-2 in oncogenesis“. BioEssays. 30 (4): 314–27. doi:10.1002/bies.20734. PMID18348191. S2CID678541.
Katoh Y, Katoh M (September 2008). „Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review)“. International Journal of Molecular Medicine. 22 (3): 271–5. PMID18698484.
Li JJ, Huang YQ, Basch R, Karpatkin S (February 2001). „Thrombin induces the release of angiopoietin-1 from platelets“. Thrombosis and Haemostasis. 85 (2): 204–6. doi:10.1055/s-0037-1615677. PMID11246533. S2CID33522255.
Gowda C, Sachdev M, Muthusami S, Kapadia M, Petrovic-Dovat L, Hartman M, et al. (2017). „Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies“. Current Pharmaceutical Design. 23 (1): 95–107. doi:10.2174/1381612822666161006154311. PMID27719640.
Zhang J, Tian XJ, Zhang H, Teng Y, Li R, Bai F, et al. (September 2014). „TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops“. Science Signaling. 7 (345): ra91. doi:10.1126/scisignal.2005304. PMID25270257. S2CID19143040.
Peinado H, Olmeda D, Cano A (2007). „Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?“. Nature Reviews Cancer. 7 (6): 415–428. doi:10.1038/nrc2131. hdl:10261/81769. PMID17508028. S2CID25162191.
De Craene B, Berx G (2013). „Regulatory networks defining EMT during cancer initiation and progression“. Nature Reviews Cancer. 13 (2): 97–110. doi:10.1038/nrc3447. PMID23344542. S2CID13619676.
Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (April 2008). „The role of ATF-2 in oncogenesis“. BioEssays. 30 (4): 314–27. doi:10.1002/bies.20734. PMID18348191. S2CID678541.
Li JJ, Huang YQ, Basch R, Karpatkin S (February 2001). „Thrombin induces the release of angiopoietin-1 from platelets“. Thrombosis and Haemostasis. 85 (2): 204–6. doi:10.1055/s-0037-1615677. PMID11246533. S2CID33522255.
Yingling JM, Blanchard KL, Sawyer JS (December 2004). „Development of TGF-beta signalling inhibitors for cancer therapy“. Nature Reviews. Drug Discovery. 3 (12): 1011–22. doi:10.1038/nrd1580. PMID15573100. S2CID42237691.
Zhang J, Tian XJ, Zhang H, Teng Y, Li R, Bai F, et al. (September 2014). „TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops“. Science Signaling. 7 (345): ra91. doi:10.1126/scisignal.2005304. PMID25270257. S2CID19143040.